NCT07586917 Optimizing Pregnancy and Treatment Interventions for Moms 3.0
| NCT ID | NCT07586917 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Opioid Abuse (Disorder) |
| Study Type | INTERVENTIONAL |
| Enrollment | 429 participants |
| Start Date | 2026-07-10 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 429 participants in total. It began in 2026-07-10 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We want to learn if Patient Navigation helps pregnant Medicaid members with opioid use disorder, with or without stimulant use disorder, stay in care, use medications for opioid use disorder, reduce substance use, and connect with services, compared to usual care. Enrolled participants will be randomly assigned (by chance, like flipping a coin) to one of two groups: Usual Care or Patient Navigation. Participate will last up to 14 months and participants randomized to Patient Navigation may have about 14 sessions/calls with a Patient Navigator (30-45 minutes each) and complete 3 surveys (30-60 minutes each). All visits can be by phone or video.
Eligibility Criteria
Inclusion Criteria: * Adult (≥18 years) * Opioid use disorder * ≥7 weeks gestation * Medication for opioid use disorder naive or newly initiated (≤6 weeks MOUD) * Provide permission to access administrative claims and medical records of their care and those of their neonate * Speak English Exclusion Criteria: * Plan to terminate pregnancy * Had a psychotic and/or manic episode in the last 30 days * Cannot provide contact information for themselves and 2 collateral contacts * Do not possess a reliable phone * Plan to move from the area ≤6 months of delivery * \>32 weeks gestation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07586917 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Opioid Abuse (Disorder). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07586917 currently recruiting?
Yes, NCT07586917 is actively recruiting participants. Contact the research team at optimom@utah.edu for enrollment information.
Where is the NCT07586917 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT07586917 clinical trial?
NCT07586917 is sponsored by University of Utah. The trial plans to enroll 429 participants.